181 results
Page 4 of 10
424B5
6oubgof411m4te4qqiz
7 Jul 20
Prospectus supplement for primary offering
4:32pm
10-K
evp7zyf0sxj x1ar
29 Jun 20
Annual report
4:02pm
8-K
EX-99.1
etiqecihs6df4s0o20o8
29 Jun 20
Acasti Pharma Provides Fiscal 2020 Year-End Business Update
12:50pm
S-3
rir8f
29 Jun 20
Shelf registration
12:00am
8-K
EX-99.1
s9xz0dvh9e7kthb78b4
19 Jun 20
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
9:09am
8-K
EX-99.1
fr624 sqd80qc4736
30 Apr 20
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
4:22pm
8-K
EX-99.1
7z712isrmtfd
20 Apr 20
Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
4:05pm
8-K
EX-99.1
txeiw4 rr4p
1 Apr 20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
5:12pm
6-K
EX-99.1
2cze8k7b
11 Mar 20
Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
8:00am
6-K
EX-99.1
jp1lznr
28 Feb 20
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
5:00pm
6-K
EX-99.2
ys9p clv3
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
ipzzqz1ns05w8h
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
eoaq13nerq5zdy0bh
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.1
5mmydvtul7c3nv4uo zy
13 Feb 20
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
9:00am
6-K
EX-99.1
fu0v wfiq10
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
EX-99.1
79kolq9ucgmvl0e2hm
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
6-K
EX-99.1
ulxba
23 Dec 19
Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
8:43pm
6-K
EX-99.1
ul1fsg
26 Nov 19
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia
7:58am
6-K
EX-99.1
dxkdx9aqi 31a
18 Nov 19
Current report (foreign)
8:46am
6-K
EX-99.1
l3eeex gl9
13 Nov 19
Current report (foreign)
7:55am